Abstract:Abstract Objective This study analyzes the potential cost-effectiveness of integrating an artificial intelligence (AI)–assisted system into the differentiation of incidental renal lesions as benign or malignant on MR images during follow-up. Materials and methods For estimation of quality-adjusted life years (QALYs) and lifetime costs, a decision model was created, including the MRI strategy and MRI + AI strategy. Model input parameters were derived from recent literature. Willingness to pay (WTP) was set to $100,000/QALY. Costs of $0 for the AI were assumed in the base-case scenario. Model uncertainty and costs of the AI system were assessed using deterministic and probabilistic sensitivity analysis. Results Average total costs were at $8054 for the MRI strategy and $7939 for additional use of an AI-based algorithm. The model yielded a cumulative effectiveness of 8.76 QALYs for the MRI strategy and of 8.77 for the MRI + AI strategy. The economically dominant strategy was MRI + AI. Deterministic and probabilistic sensitivity analysis showed high robustness of the model with the incremental cost-effectiveness ratio (ICER), which represents the incremental cost associated with one additional QALY gained, remaining below the WTP for variation of the input parameters. If increasing costs for the algorithm, the ICER of $0/QALY was exceeded at $115, and the defined WTP was exceeded at $667 for the use of the AI. Conclusions This analysis, rooted in assumptions, suggests that the additional use of an AI-based algorithm may be a potentially cost-effective alternative in the differentiation of incidental renal lesions using MRI and needs to be confirmed in the future. Clinical relevance statement These results hint at AI’s the potential impact on diagnosing renal masses. While the current study urges careful interpretation, ongoing research is essential to confirm and seamlessly integrate AI into clinical practice, ensuring its efficacy in routine diagnostics. Key Points • This is a model-based study using data from literature where AI has been applied in the diagnostic workup of incidental renal lesions. • MRI + AI has the potential to be a cost-effective alternative in the differentiation of incidental renal lesions. • The additional use of AI can reduce costs in the diagnostic workup of incidental renal lesions.

Letter to the Editor on the Article: “Comparison of Magnetic Resonance Imaging and Contrast-Enhanced Ultrasound as Diagnostic Options for Unclear Cystic Renal Lesions: A Cost-Effectiveness Analysis”

Contrast-Enhanced Ultrasound as a Diagnostic Procedure in Renal Diseases: A Case Report

Diagnostic Value of Contrast-Enhanced Ultrasound in Differentiating Malignant from Benign Small Renal Masses After CT/MRI

A Comparison Analysis of Contrast-Enhanced Ultrasonography and Contrast-Enhanced Computed-Tomography in the Diagnosis of Renal Lesions

Contrast enhanced ultrasound of cystic renal lesions, from diagnosis up to treatment

Contrast-enhanced ultrasound in renal cystic lesions: an update

Contrast-enhanced Ultrasound for Differentiating Benign from Malignant Solid Small Renal Masses: Comparison with Contrast-Enhanced CT

Diagnostic value of contrast-enhanced ultrasound (CEUS) in kidney allografts - 12 years of experience in a tertiary referral center

0665: Contrast-Enhanced Ultrasound in the Diagnosis of Cystic Renal Lesion

The current role of contrast-enhanced ultrasound (CEUS) imaging in the evaluation of renal pathology

Contrast-enhanced Ultrasonography for Evaluation of Cystic Renal Mass: in Comparison to Contrast-Enhanced CT and Conventional Ultrasound

Contrast-enhanced ultrasound for characterizing renal masses

Expanding the Role of Ultrasound for the Characterization of Renal Masses

Contrast-Enhanced Ultrasound of the Indeterminate Renal Mass, From the AJR “How We Do It” Special Series

Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Renal Masses with Histopathological Validation—Results from a Prospective Single-Center Study

Comparison of Contrast-Enhanced Sonography with MRI in the Diagnosis of Complex Cystic Renal Masses

CEUS Bosniak Classification-Time for Differentiation and Change in Renal Cyst Surveillance

Contrast Enhanced Ultrasound Compared with MRI and CT in the Evaluation of Post-Renal Transplant Complications

Diagnostic Performance of Contrast-Enhanced Ultrasound in Testicular Space-Occupying Lesions: A Systematic Review and Meta-analysis

Artificial intelligence support in MR imaging of incidental renal masses: an early health technology assessment

[Application of Contrast-Enhanced Ultrasound in the Diagnosis of Renal Cystic Lesion].